Model‐informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease

por Willmann, Stefan, Ince, Ibrahim, Ahsman, Maurice, Coboeken, Katrin, Zhang, Yang, Thelen, Kirstin, Kubitza, Dagmar, Zannikos, Peter, Zhou, Wangda, Pina, Liza Miriam, Post, Teun, Lippert, Jörg
Publicado 2022

Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study

por Zhu, Peijuan, Willmann, Stefan, Zhou, Wangda, Yang, Haitao, Michelson, Alan D., McCrindle, Brian W., Li, Jennifer S., Harris, Kevin C., Pina, Liza Miriam, Weber, Traci, Nessel, Kimberly, Lesko, Lawrence J., Kubitza, Dagmar, Zannikos, Peter
Publicado 2022